Works matching AU Gallamini, Andrea

Results: 65
    1
    2

    Role of PET in Lymphoma.

    Published in:
    Current Treatment Options in Oncology, 2014, v. 15, n. 2, p. 248, doi. 10.1007/s11864-014-0278-4
    By:
    • Gallamini, Andrea;
    • Borra, Anna
    Publication type:
    Article
    3

    Michel Meignan, MD, PhD, 1947-2022.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 342
    By:
    • Barrington, Sally;
    • Buvat, Irèene;
    • Cottereau, Anne-Ségolène;
    • Gallamini, Andrea;
    • Thieblemont, Catherine
    Publication type:
    Article
    4

    Richard C. Reba, MD, 1932-2022.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 342
    By:
    • Barrington, Sally;
    • Buvat, Irèene;
    • Cottereau, Anne-Ségolène;
    • Gallamini, Andrea;
    • Thieblemont, Catherine
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11

    The prognostic value of positron emission tomography performed after two courses ( INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 6, p. 499, doi. 10.1002/ajh.23994
    By:
    • Rigacci, Luigi;
    • Puccini, Benedetta;
    • Zinzani, Pier Luigi;
    • Biggi, Alberto;
    • Castagnoli, Antonio;
    • Merli, Francesco;
    • Balzarotti, Monica;
    • Stelitano, Caterina;
    • Spina, Michele;
    • Vitolo, Umberto;
    • Stefoni, Vittorio;
    • Levis, Alessandro;
    • Gotti, Manuel;
    • Rosaria, Sancetta;
    • Maria, Stefani Piero;
    • Bosi, Alberto;
    • Gallamini, Andrea
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    T021: Radiation‐Free Therapy as the INitial treatment of Good‐prognosis early non‐bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET‐2 ‐ RAFTING Trial.

    Published in:
    HemaSphere, 2022, v. 6, p. 10, doi. 10.1097/01.HS9.0000890652.56016.97
    By:
    • Gallamini, Andrea;
    • Picardi, Marco;
    • Filonenko, Kateryna;
    • Gotti, Manuel;
    • Céspedes, Javier Núñez;
    • Rossi, Andrea;
    • Domingo‐Domènech, Eva;
    • Giza, Agnieszka;
    • Sorasio, Roberto;
    • Trentin, Livio;
    • Oteiro, Mariana Bastos;
    • Paszkiewicz‐Kozik, Ewa;
    • Sanz, Ramon García;
    • Patti, Caterina;
    • Chauvie, Stephane;
    • Bergesio, Fabrizio;
    • Guerra, Luca;
    • Rambaldi, Alessandro;
    • Balari, Ana Sureda;
    • Zaucha, Jan Maciej
    Publication type:
    Article
    24
    25

    P009: Improved Overall Survival with First‐Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON‐1.

    Published in:
    HemaSphere, 2022, v. 6, p. 4, doi. 10.1097/01.HS9.0000890604.66330.a0
    By:
    • Hutchings, Martin;
    • Ansell, Stephen M.;
    • Connors, Joseph M.;
    • Kim, Won Seog;
    • Gallamini, Andrea;
    • Ramchandren, Radhakrishnan;
    • Friedberg, Jonathan W.;
    • Advani, Ranjana;
    • Evens, Andrew M.;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Eom, Hyeon‐Seok;
    • Abramson, Jeremy S.;
    • Dong, Cassie;
    • Campana, Frank;
    • Fenton, Keenan;
    • Puhlmann, Markus;
    • Straus, David J.;
    • Radford, John
    Publication type:
    Article
    26

    P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim‐PET (PET‐2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patient data of three multicenter trials.

    Published in:
    HemaSphere, 2022, v. 6, p. 2, doi. 10.1097/01.HS9.0000890584.35232.1f
    By:
    • Viviani, Simonetta;
    • Pavoni, Chiara;
    • Barrington, Sally F.;
    • Guerra, Luca;
    • Schöder, Heiko;
    • Johnson, Peter;
    • Kirkwood, Amy A.;
    • Stephens, Deborah M.;
    • Friedberg, Jonathan W.;
    • Chauvie, Stephane;
    • Knopp, Michael V.;
    • Federico, Massimo;
    • Enblad, Gunilla;
    • Corradini, Paolo;
    • Gallamini, Andrea;
    • Rambaldi, Alessandro;
    • Tarella, Corrado
    Publication type:
    Article
    27

    Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 12, p. 2931, doi. 10.1080/10428194.2020.1791846
    By:
    • Straus, David;
    • Collins, Graham;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Grigg, Andrew;
    • Sureda, Anna;
    • Illes, Arpad;
    • Kim, Tae Min;
    • Alekseev, Sergey;
    • Specht, Lena;
    • Buccheri, Valeria;
    • Younes, Anas;
    • Connors, Joseph;
    • Forero-Torres, Andres;
    • Fenton, Keenan;
    • Gautam, Ashish;
    • Purevjal, Indra;
    • Liu, Rachael;
    • Gallamini, Andrea
    Publication type:
    Article
    28
    29

    Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 5, p. 1233, doi. 10.3109/10428194.2015.1034707
    By:
    • Zwarthoed, Cholette;
    • Ouvier, Matthieu John;
    • Borra, Anna;
    • Bergesio, Fabrizio;
    • Chauvie, Stephane;
    • Biggi, Alberto;
    • Hutchings, Martin;
    • El-Galaly, Tarek;
    • Gallamini, Andrea;
    • Simon, Zsófia;
    • Miltényi, Zsófia;
    • Magyari, Ferenc;
    • Barna, Sándor;
    • Kenyeres, Anna;
    • Jóna, Ádám;
    • Illés, Árpád;
    • Dann, Eldad J.;
    • Bar-Shalom, Rachel;
    • Kagana, Olga;
    • Bairey, Osnat
    Publication type:
    Article
    30
    31
    32
    33
    34

    Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 551, doi. 10.1111/j.1365-2141.2010.08485.x
    By:
    • Gallamini, Andrea;
    • Patti, Caterina;
    • Viviani, Simonetta;
    • Rossi, Andrea;
    • Fiore, Francesca;
    • Di Raimondo, Francesco;
    • Cantonetti, Maria;
    • Stelitano, Caterina;
    • Feldman, Tatyana;
    • Gavarotti, Paolo;
    • Sorasio, Roberto;
    • Mulè, Antonino;
    • Leone, Monica;
    • Rambaldi, Alessandro;
    • Biggi, Alberto;
    • Barrington, Sally;
    • Fallanca, Federico;
    • Ficola, Umberto;
    • Chauvie, Stéphane;
    • Gianni, Alessandro Massimo
    Publication type:
    Article
    35

    Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 2, p. 301, doi. 10.1111/j.1365-2141.2006.06437.x
    By:
    • Arcaini, Luca;
    • Paulli, Marco;
    • Burcheri, Sara;
    • Rossi, Andrea;
    • Spina, Michele;
    • Passamonti, Francesco;
    • Lucioni, Marco;
    • Motta, Teresio;
    • Canzonieri, Vincenzo;
    • Montanari, Mauro;
    • Bonoldi, Emanuela;
    • Gallamini, Andrea;
    • Uziel, Lilj;
    • Crugnola, Monica;
    • Ramponi, Antonio;
    • Montanari, Francesca;
    • Pascutto, Cristiana;
    • Morra, Enrica;
    • Lazzarino, Mario
    Publication type:
    Article
    36
    37
    38

    Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim <sup>18</sup>F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.

    Published in:
    Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 410, doi. 10.23736/S1824-4785.17.02993-4
    By:
    • BIGGI, Alberto;
    • BERGESIO, Fabrizio;
    • CHAUVIE, Stephane;
    • BIANCHI, Andrea;
    • MENGA, Massimo;
    • FALLANCA, Federico;
    • HUTCHINGS, Martin;
    • GREGIANIN, Michele;
    • MEIGNAN, Michel;
    • GALLAMINI, Andrea
    Publication type:
    Article
    39
    40

    Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 712, doi. 10.1007/s00259-017-3909-8
    By:
    • Nanni, Cristina;
    • Versari, Annibale;
    • Chauvie, Stephane;
    • Bertone, Elisa;
    • Bianchi, Andrea;
    • Rensi, Marco;
    • Bellò, Marilena;
    • Gallamini, Andrea;
    • Patriarca, Francesca;
    • Gay, Francesca;
    • Gamberi, Barbara;
    • Ghedini, Pietro;
    • Cavo, Michele;
    • Fanti, Stefano;
    • Zamagni, Elena
    Publication type:
    Article
    41

    Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 3, p. 414, doi. 10.1007/s00259-015-3200-9
    By:
    • Nanni, Cristina;
    • Zamagni, Elena;
    • Versari, Annibale;
    • Chauvie, Stephane;
    • Bianchi, Andrea;
    • Rensi, Marco;
    • Bellò, Marilena;
    • Rambaldi, Ilaria;
    • Gallamini, Andrea;
    • Patriarca, Francesca;
    • Gay, Francesca;
    • Gamberi, Barbara;
    • Cavo, Michele;
    • Fanti, Stefano
    Publication type:
    Article
    42

    FDG PET/CT imaging as a biomarker in lymphoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 4, p. 623, doi. 10.1007/s00259-014-2973-6
    By:
    • Meignan, Michel;
    • Itti, Emmanuel;
    • Gallamini, Andrea;
    • Younes, Anas
    Publication type:
    Article
    43

    Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 11, p. 2017, doi. 10.1007/s00259-014-2822-7
    By:
    • Sasanelli, Myriam;
    • Meignan, Michel;
    • Haioun, Corinne;
    • Berriolo-Riedinger, Alina;
    • Casasnovas, René-Olivier;
    • Biggi, Alberto;
    • Gallamini, Andrea;
    • Siegel, Barry;
    • Cashen, Amanda;
    • Véra, Pierre;
    • Tilly, Hervé;
    • Versari, Annibale;
    • Itti, Emmanuel
    Publication type:
    Article
    44

    An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 9, p. 1312, doi. 10.1007/s00259-013-2435-6
    By:
    • Itti, Emmanuel;
    • Meignan, Michel;
    • Berriolo-Riedinger, Alina;
    • Biggi, Alberto;
    • Cashen, Amanda F.;
    • Véra, Pierre;
    • Tilly, Hervé;
    • Siegel, Barry A.;
    • Gallamini, Andrea;
    • Casasnovas, René-Olivier;
    • Haioun, Corinne
    Publication type:
    Article
    45

    Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.

    Published in:
    British Journal of Haematology, 1984, v. 58, n. 4, p. 689, doi. 10.1111/j.1365-2141.1984.tb06116.x
    By:
    • Boccadoro, Mario;
    • Gavarotti, Paolo;
    • Fossati, Giorgio;
    • Pileri, Alessandro;
    • Marmont, Filippo;
    • Neretto, Giorgio;
    • Gallamini, Andrea;
    • Volta, Carla;
    • Tribalto, Maurizio;
    • Testa, Maria G.;
    • Amadori, Sergio;
    • Mandelli, Franco;
    • Durie, Brian G. M.
    Publication type:
    Article
    46

    International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1343, doi. 10.2967/jnumed.124.267789
    By:
    • Boellaard, Ronald;
    • Buvat, Irène;
    • Nioche, Christophe;
    • Ceriani, Luca;
    • Cottereau, Anne-Ségolène;
    • Guerra, Luca;
    • Hicks, Rodney J.;
    • Kanoun, Salim;
    • Kobe, Carsten;
    • Loft, Annika;
    • Schöder, Heiko;
    • Versari, Annibale;
    • Voltin, Conrad-Amadeus;
    • Zwezerijnen, Gerben J.C.;
    • Zijlstra, Josée M.;
    • Mikhaeel, N. George;
    • Gallamini, Andrea;
    • El-Galaly, Tarec C.;
    • Hanoun, Christine;
    • Chauvie, Stephane
    Publication type:
    Article
    47
    48

    Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
    By:
    • Hutchings, Martin;
    • Radford, John;
    • Ansell, Stephen M.;
    • Illés, Árpád;
    • Sureda, Anna;
    • Connors, Joseph M.;
    • Sýkorová, Alice;
    • Shibayama, Hirohiko;
    • Abramson, Jeremy S.;
    • Chua, Neil S.;
    • Friedberg, Jonathan W.;
    • Kořen, Jan;
    • LaCasce, Ann Steward;
    • Molina, Lysiane;
    • Engley, Gerald;
    • Fenton, Keenan;
    • Jolin, Hina;
    • Liu, Rachael;
    • Gautam, Ashish;
    • Gallamini, Andrea
    Publication type:
    Article
    49

    Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET‐adapted strategy.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 4, p. 501, doi. 10.1002/hon.2775
    By:
    • Viviani, Simonetta;
    • Mazzocchi, Arabella;
    • Pavoni, Chiara;
    • Taverna, Francesca;
    • Rossi, Andrea;
    • Patti, Caterina;
    • Romano, Alessandra;
    • Trentin, Livio;
    • Sorasio, Roberto;
    • Guidetti, Anna;
    • Gottardi, Daniela;
    • Tarella, Corrado;
    • Cimminiello, Michele;
    • Zanotti, Roberta;
    • Farina, Lucia;
    • Ferreri, Andrés José Maria;
    • Galbiati, Marina;
    • Corradini, Paolo;
    • Gianni, Alessandro Massimo;
    • Gallamini, Andrea
    Publication type:
    Article
    50